Constructed Data to Be Accessible for All
Researchers, Industry Stakeholders, and the General Public Alike

The National Institute for Korean Medicine Development signed a business agreement with the Ochang Branch of the Korea Research Institute of Bioscience and Biotechnology to revitalize the Korean medicine industry through the joint use of experimental information in the field of herbal medicine.

The National Institute for Korean Medicine Development signed a business agreement with the Ochang Branch of the Korea Research Institute of Bioscience and Biotechnology to revitalize the Korean medicine industry through the joint use of experimental information in the field of herbal medicine.

View original image

[The Asia Business Daily Yeongnam Bureau Reporter Yeo Jonggu] The National Institute for Korean Medicine Development signed a business agreement with the Ochang Branch of the Korea Research Institute of Bioscience and Biotechnology to jointly utilize experimental information in the field of herbal medicine (natural products and medicinal herbs) and to revitalize the Korean medicine industry.


This agreement was promoted in accordance with the National Institute for Korean Medicine Development's "Korean Medicine Artificial Intelligence Platform Construction Project" under the 4th Comprehensive Plan for the Development and Promotion of Korean Medicine (2021-2025), and the Ochang Branch's "Natural Products Cluster Development Project" of the Korea Research Institute of Bioscience and Biotechnology.


Going forward, both institutions will actively support the sharing and mutual use of experimental information necessary for building a database. They plan to cooperate so that the constructed data can be utilized not only by researchers and industry stakeholders but also by the general public.


The National Institute for Korean Medicine Development will also promote the preparation of standard datasets, data analysis and processing, and the establishment of a foundation for utilizing the data for artificial intelligence training, as well as cooperation with various institutions, to build an integrated database of herbal medicine experimental data both within and outside the organization.


Additionally, the Ochang Branch of the Korea Research Institute of Bioscience and Biotechnology, which oversees the Natural Products Cluster Development Project and operates the Central Bank of Natural Products, will establish base banks at the KIST Natural Products Research Institute, the Naju Center of the Korea Institute of Oriental Medicine, and the functional food hub institution (to be selected in July 2022). In January next year, it plans to launch a portal integrating domestic and international plant resources.


Furthermore, it aims to establish standard procedures for securing, extracting, analyzing, and evaluating the efficacy of natural product materials, distribute standard extracts, and build a system for utilizing natural product information to provide to academia, industry, and research institutions.


Jung Changhyun, President of the National Institute for Korean Medicine Development, stated, "This agreement marks the beginning of inter-institutional cooperation to meet the demand for joint utilization of domestic and international research data," adding, "We will strive to ensure that the research data of both institutions provides practical benefits to researchers, industry stakeholders, and the general public."





This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing